AAA
Affinity Asset Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Sell |
24,692
-25,000
| -50% | -$1.27M | 0.17% | 59 |
|
|
2025
Q1 | $2.24M | Sell |
49,692
-21,050
| -30% | -$948K | 0.21% | 51 |
|
|
2024
Q4 | $2.93M | Sell |
70,742
-4,258
| -6% | -$176K | 0.39% | 45 |
|
|
2024
Q3 | $2.93M | Sell |
75,000
-80,000
| -52% | -$3.12M | 0.4% | 50 |
|
|
2024
Q2 | $5.3M | Sell |
155,000
-5,000
| -3% | -$171K | 0.61% | 40 |
|
|
2024
Q1 | $4.02M | Buy |
160,000
+110,000
| +220% | +$2.76M | 0.5% | 48 |
|
|
2023
Q4 | $1.48M | Buy |
50,000
+20,000
| +67% | +$590K | 0.27% | 54 |
|
|
2023
Q3 | $948K | Hold |
30,000
| – | – | 0.27% | 53 |
|
|
2023
Q2 | $776K | Sell |
30,000
-65,000
| -68% | -$1.68M | 0.27% | 50 |
|
|
2023
Q1 | $2.28M | Buy |
95,000
+55,000
| +138% | +$1.32M | 0.75% | 33 |
|
|
2022
Q4 | $780K | Buy |
+40,000
| New | +$780K | 0.31% | 44 |
|